These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 12392300)
1. Comparative measurement of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure. Masson S; Vago T; Baldi G; Salio M; De Angelis N; Nicolis E; Maggioni AP; Latini R; Norbiato G; Bevilacqua M Clin Chem Lab Med; 2002 Aug; 40(8):761-3. PubMed ID: 12392300 [TBL] [Abstract][Full Text] [Related]
2. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378 [TBL] [Abstract][Full Text] [Related]
3. Comparative value of BNP and NT-proBNP in diagnosis of heart failure. Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324 [TBL] [Abstract][Full Text] [Related]
4. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea. Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931 [TBL] [Abstract][Full Text] [Related]
5. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Bruins S; Fokkema MR; Römer JW; Dejongste MJ; van der Dijs FP; van den Ouweland JM; Muskiet FA Clin Chem; 2004 Nov; 50(11):2052-8. PubMed ID: 15345664 [TBL] [Abstract][Full Text] [Related]
6. Analytical correlation between plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in patients presenting with dyspnea. Alibay Y; Beauchet A; El Mahmoud R; Brun-Ney D; Alexandre JA; Benoit MO; Dubourg O; Aegerter P; Boileau C; Jondeau G; Puy H Clin Biochem; 2004 Oct; 37(10):933-6. PubMed ID: 15369727 [TBL] [Abstract][Full Text] [Related]
7. Risk of cardiovascular death in elderly patients with possible heart failure. B-type natriuretic peptide (BNP) and the aminoterminal fragment of ProBNP (N-terminal proBNP) as prognostic indicators in a 6-year follow-up of a primary care population. Alehagen U; Lindstedt G; Levin LA; Dahlström U Int J Cardiol; 2005 Apr; 100(1):125-33. PubMed ID: 15820295 [TBL] [Abstract][Full Text] [Related]
12. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease]. Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803 [TBL] [Abstract][Full Text] [Related]
13. [Amino-terminal pro-brain natriuretic peptide and brain natriuretic peptide measurements under various detection conditions in patients with chronic heart failure]. Wang WJ; Zhang XM; Wang Q; Wen DM; Ouyang NL; Cui YL; Li F Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):695-9. PubMed ID: 22169413 [TBL] [Abstract][Full Text] [Related]
14. [Changes of serum N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases and its clinical significance]. Yang CL; Qiu YR; Zhou F; Feng PF Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):866-9. PubMed ID: 18504223 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Mueller T; Gegenhuber A; Poelz W; Haltmayer M Heart; 2005 May; 91(5):606-12. PubMed ID: 15831643 [TBL] [Abstract][Full Text] [Related]
16. Correlation of B type natriuretic peptides with clinical and echocardiographic parameters in heterogeneous population of patients with symptoms suggestive of heart failure. Piechota WN; Piechota WT; Bejm J; Wierzbowski R; Michałkiewicz D Adv Med Sci; 2006; 51():164-7. PubMed ID: 17357300 [TBL] [Abstract][Full Text] [Related]
18. Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure. Miller WL; Hartman KA; Grill DE; Burnett JC; Jaffe AS Clin Chem; 2009 Jan; 55(1):78-84. PubMed ID: 19028821 [TBL] [Abstract][Full Text] [Related]
19. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure. Rothenburger M; Wichter T; Schmid C; Stypmann J; Tjan TD; Berendes E; Etz C; Pioux A; Löher A; Wenzelburger F; Drees G; Hoffmeier A; Breithardt G; Scheld HH J Heart Lung Transplant; 2004 Oct; 23(10):1189-97. PubMed ID: 15477114 [TBL] [Abstract][Full Text] [Related]
20. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases. Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]